Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_assertion type Assertion NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_head.
- NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_assertion description "[To determine whether the expression of vascular endothelial growth factor (VEGF) is altered by treatment in an in vivo tumor with 17 beta-estradiol (E2) or medroxyprogesterone acetate (MPA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_provenance.
- NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_assertion evidence source_evidence_literature NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_provenance.
- NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_assertion SIO_000772 8626126 NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_provenance.
- NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_assertion wasDerivedFrom befree-20140225 NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_provenance.
- NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_assertion wasGeneratedBy ECO_0000203 NP442115.RAxqBRf8IwfYw26xDGvw4-zu7HERybvJKJXhfW2-4-dTA130_provenance.